Dr. Vitiello et al. reply.
Benedetto
B
Vitiello
Mark A
MA
Riddle
Gayane Yenokyan
David A
DA
Axelson
Boris
B
Birmaher
Neal D
ND
Ryan
Karen D
KD
Wagner
Paramjit
P
Joshi
Adelaide
A
Robb
John T
JT
Walkup
Joan
J
Luby
Rebecca Tillman
Graham
G
Emslie
D000927:Anticonvulsants / Q000627:therapeutic use*; D018692:Antimanic Agents / Q000627:therapeutic use*; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D001714:Bipolar Disorder / Q000175:diagnosis* / Q000188:drug therapy*; D005260:Female; D006801:Humans; D016651:Lithium Carbonate / Q000627:therapeutic use*; D008297:Male; D010348:Patient Care Team; D018967:Risperidone / Q000627:therapeutic use*; D014635:Valproic Acid / Q000627:therapeutic use*
D000927:Anticonvulsants; D018692:Antimanic Agents; D014150:Antipsychotic Agents; D016651:Lithium Carbonate; D014635:Valproic Acid; D018967:Risperidone